OR WAIT null SECS
September 08, 2021
After previously going bankrupt, center is now under US ownership for the first time
September 02, 2021
Swiss organization will take patient-centric approach towards developing injectables
September 01, 2021
Company’s prospective malaria and tuberculosis doses will be developed in Rwanda, Senegal
Irvine, CA, location will house 40,000 square feet of oral solid dosage forms
August 25, 2021
Swiss CDMO’s expansion at recently opened Guangzhou plant expected to be ready by next year
August 24, 2021
Venture anticipated to more than double single-use bioreactor mammalian cell-culture capacity on site
August 20, 2021
CDMO's expansion of Rensselaer, NY, facility will help grow its API division
August 19, 2021
Acquisition addresses the need for meeting healthcare sector’s patient support demand
August 18, 2021
Cardiff center will help produce lipids that are necessary for mRNA Covid vaccines
August 17, 2021
Developments include the creation of a new microbial facility, expansion of mammalian center